Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The preclinical T-cell engagers will be developed using Amberstone’s Tumor Micro...
This treatment is approved for use alongside diet and exercise to improve blood ...
The companies will integrate the Genialis Supermodel with Inventia’s RASTRUM 3D ...
S32 led the oversubscribed financing round. Investors included Catalio Capital M...
India’s emerging True MRP generic pharmacy network expands rapidly since its No...
Under the agreement, Envisagenics is set to receive more than $1bn through poten...
The agreement includes an upfront payment, as well as potential development, reg...
Traya has treated hair loss as a health issue rather than simply a cosmetic con...
A recent essay in Express Pharma by Mr. S. Swaminathan, CEO of GS1 India, extol...
ERS Genomics Limited (‘ERS’), the CRISPR licensing company, announced that it h...
Corporate history is replete with examples of the ‘third generation curse’, but...
The authorisation allows both treatments to be used for patients with primary hy...
The company said programmes could be onboarded at the facility immediately, rath...
The pharmaceutical industry is increasingly focusing on integrating Green and S...
BDR Pharmaceuticals International Pvt Ltd has announced the appointment of Nira...
For much of the past two decades, global biotech leadership has clustered aroun...